Imperative Care has completed subject enrolment in the pivotal investigational device exemption (IDE) trial, SYMPHONY-PE, ...

Imperative Care Launches its Next Innovation to Elevate Ischemic Stroke Treatment and Announces First Patients Treated with Continuous Dual Aspiration Technique The New Continuous Dual Aspiration ...

Imperative Care has announced positive data from a study of its Zoom reperfusion system, suggesting reduced rates of rescue therapy than prior thrombectomy trials, and faster and higher rates of ...

The ZOOM Reperfusion Catheters complement Imperative Care’s line of access catheters. These access catheters are designed to be longer and more flexible than other catheters, enabling smooth ...

Imperative Care has received 510(k ... The company has also received FDA clearance for its ZOOM Aspiration System, a family of products designed to facilitate clot removal during ischemic stroke.

executive vice president and general manager of Imperative Care’s stroke business, said in a statement. “The Zoom System is the first purpose-built technology from access to aspiration that ...

In a press release, device manufacturer Imperative Care Inc. said the Zoom System is “the first comprehensive stroke thrombectomy system to include large-bore .088 catheters indicated for both ...

April 15, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced it will ... trial comparing aspiration thrombectomy with the Zoom Stroke System plus best medical treatment versus best ...

Among Imperative Care Stroke’s offerings is the Zoom Stroke Solution, an all-in-one system that doctors can use throughout the entire process of treating ischemic and hemorrhagic stroke ...

Imperative Care announced today that it completed enrollment in the SYMPHONY-PE pivotal investigational device exemption (IDE ...

More than 30,000 patients have been treated with Imperative Care Stroke products to date, and the company’s Zoom™ Stroke Solution is one of the most complete stroke treatment solutions available today ...